Showing results (2241-2250 of 5,610) with videos related to
Sort By:
Pageof 561
Human Immunology|January 16, 2010
APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sampleJaroslav A Hubacek, Anne Peasey, Hynek Pikhart, et al.Human Immunology|January 1, 1994
Idiotype-specific autologous T-cell interactions restricted by HLA-DRN K Garlie, D D EckelsHuman Immunology|December 1, 1993
HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformisM A Hall, J S Lanchbury, J S Lee, et al.Human Immunology|October 1, 1993
A silent mutation in HLA-DPB1*0101 and its evolutionary implicationsC G Meyer, L SchnittgerHuman Immunology|October 1, 1993
Complete nucleotide sequence of HLA-B*0703, a B7 variant (BPOT)A M Bergmans, H Tijssen, N Lardy, et al.Human Immunology|November 1, 1993
TAP2 gene polymorphism segregates with DR-DQ in DR/DP recombinant siblingsT H Eiermann, J Fakler, S F Goldmann, et al.Human Immunology|November 1, 1993
Alloactivation induced during mixed-lymphocyte reaction provokes release of tumor necrosis factor alpha and interleukin 6 by macrophages and primes them to lipopolysaccharidesM Toungouz, C H Denys, D De Groote, et al.Human Immunology|November 1, 1993
Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjectsC Caruso, G Candore, A T Colucci, et al.Human Immunology|October 12, 2005
Analysis of a GT microsatellite in the promoter of the foxp3/scurfin gene in autoimmune diseasesElena Sánchez, Blanca Rueda, Gisela Orozco, et al.Human Immunology|October 12, 2005
Continuous presence of Th1 conditions is necessary for longer lasting tumor-specific CTL activity in stimulation cultures with PBLSubhasis Chattopadhyay, Nitya G ChakrabortyPageof 561